CYP cynata therapeutics limited

Ann: First Patient Treated in Phase 2 GvHD Trial, page-8

  1. 4,455 Posts.
    lightbulb Created with Sketch. 1602
    Hi Pledge,

    CYP management, have secured FDA approval, to run the trial in for aGVHD, as per the announcement and reported on Hot Copper.

    https://hotcopper.com.au/data/attachments/6014/6014093-14d780fd5de5a1e4ac79a00d14e82076.jpg
    Not like your beloved company, after 10 years, of trying haven't received any approval for anything, but taking those share holders for a ride to No Where.

    That why they are talking about class action against the company.

    IMHO.

    Regards

    Rossi70
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
18.5¢
Change
0.000(0.00%)
Mkt cap ! $41.80M
Open High Low Value Volume
18.0¢ 18.5¢ 17.5¢ $30.66K 167.5K

Buyers (Bids)

No. Vol. Price($)
1 17642 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 75000 1
View Market Depth
Last trade - 15.39pm 11/08/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.